The P-Mn/TI@mHSA platforms ability to target vascular injury site and facilitate deep lesion penetration, along with its favorable drug-loading capacity, makes it a promising candidate for the controlled delivery of other therapeutics, such as thrombolytic agents
High-resolution mass spectrometry (HRMS) In addition to MS/MS, high-resolution mass spectrometry (HRMS) is becoming increasingly important
Managing and Preventing Itching During Semaglutide Treatment If itching develops during semaglutide therapy, several evidence-based strategies can provide relief
Since it bypasses the digestive tract, its primary weakness (gastric instability) is irrelevant in this context
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
The dual GIP and GLP-1 mechanism indicates that more studies are needed to confirm how well GLP-1 and GIP supplements work and how safe they are over the long term